… thyroid cancer (DTC) showed the need of a personalized management approach.
Despite the increased diagnosis of DTC, in particular small papillary thyroid cancers, cancer-related …

Thyroid cancer (TC) is the most prevalent endocrine malignancy. More than 90 % of TC is
represented by differentiated TC (DTC) arising from the follicular thyroid cells. DTC includes …

… Thyroid cancer is the most common endocrine cancer. The discovery of new biomarkers for
thyroid cancer … of thyroid cancer, thus allowing more personalized treatments for patients with …

… Thyroid cancers (TC) have increasingly been detected … step toward the goal of personalized
medicine. The diagnosis of … with several challenges regarding personalized care in TC, for …

… Based on the clinical experience of five thyroid cancer experts, we provide a suggested
approach for assessing and diagnosing thyroid nodules in clinical practice, as well as our …

… thyroid cancer is Differentiated Thyroid Cancer (DTC) representing more than 95% of cases
[1]. It had become the most common cancer in women by the year 2020 after breast cancer, …

… The treatment of anaplastic thyroid cancer (ATC) has continued to rapidly evolve over
time. Increased utilization of novel, personalized therapies based upon the tumour's somatic …

… clinical practice in the future, briefly describe the resistance mechanisms of targeted therapies,
emphasizing that personalized medicine is critical to the design of second-line therapies. …

… is being developed, including personalized therapies with kinase inhibitors. Recent molecular
studies on TCs demonstrate that kinase inhibitor-based therapies might be considered as …

Two-thirds of differentiated thyroid cancer (DTC) patients with distant metastases would be
classified as radioactive iodine-refractory (RAIR-DTC), evolving into a poor outcome. Recent …